Evidence map›Paper›PMID 21273697›Full record

ArticleJournal of genetics2010

Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism.

G Gromadzka, G Chabik, T Mendel, A Wierzchowska, M Rudnicka, A Czlonkowska

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Biomarkers for diagnosis of Wilson's disease.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Article
  3. Review
  4. Monitoring of Copper in Wilson Disease.Diagnostics (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Transcranial sonography changes in heterozygotic carriers of the ATP7B gene.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2014
    Article
  19. Challenges and Recent Advances in Diagnosing Wilson Disease.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

G GromadzkaInstitute of Psychiatry and Neurology, Second Department of Neurology, 02-957 Warsaw, Poland. gromadz@ipin.edu.pl
G Chabik
T Mendel
A Wierzchowska
M Rudnicka
A Czlonkowska

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HeterozygoteAdenosine TriphosphatasesCase-Control StudiesCation Transport ProteinsCopperCopper-Transporting ATPasesFemaleHepatolenticular DegenerationHumansLiver Function TestsMaleMiddle AgedMutationPhenotypeSequence Analysis, DNAAdenosine TriphosphatasesCation Transport ProteinsCopperCopper-Transporting ATPases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.